🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/06/2009 | 11,42 | 11,42 | 10,89 | 11,38 | +0,33% | 4,59% | 85.547 |
| 09/06/2009 | 11,30 | 11,42 | 10,93 | 11,34 | +1,34% | 4,30% | 57.628 |
| 08/06/2009 | 11,53 | 11,60 | 11,15 | 11,19 | -3,86% | 3,90% | 61.956 |
| 05/06/2009 | 11,60 | 11,75 | 11,42 | 11,64 | +0,32% | 2,90% | 52.151 |
| 04/06/2009 | 11,34 | 11,64 | 10,67 | 11,60 | +3,33% | 8,58% | 107.428 |
| 03/06/2009 | 11,04 | 11,30 | 10,89 | 11,23 | +1,01% | 3,73% | 130.832 |
| 02/06/2009 | 11,15 | 11,42 | 10,89 | 11,12 | -1,00% | 4,70% | 129.255 |
| 01/06/2009 | 11,23 | 11,45 | 10,74 | 11,23 | +0,67% | 6,33% | 119.557 |
| 29/05/2009 | 10,85 | 11,15 | 10,33 | 11,15 | +2,76% | 7,59% | 147.316 |
| 28/05/2009 | 10,67 | 10,93 | 10,29 | 10,85 | +3,20% | 5,96% | 160.674 |
| 27/05/2009 | 10,37 | 10,85 | 10,29 | 10,52 | +0,72% | 5,41% | 72.643 |
| 26/05/2009 | 9,39 | 10,56 | 9,39 | 10,44 | +8,98% | 12,35% | 103.634 |
| 22/05/2009 | 9,73 | 9,99 | 9,54 | 9,58 | -1,16% | 4,62% | 49.132 |
| 21/05/2009 | 9,99 | 10,07 | 9,58 | 9,69 | -5,13% | 4,87% | 72.375 |
| 20/05/2009 | 10,11 | 10,37 | 10,07 | 10,22 | -1,44% | 2,96% | 109.405 |
| 19/05/2009 | 10,89 | 11,00 | 10,07 | 10,37 | -2,81% | 8,59% | 97.169 |
| 18/05/2009 | 10,18 | 10,67 | 9,77 | 10,67 | +6,74% | 8,82% | 96.207 |
| 15/05/2009 | 10,26 | 10,26 | 9,77 | 9,99 | -2,55% | 4,74% | 87.337 |
| 14/05/2009 | 9,69 | 11,04 | 9,69 | 10,26 | +6,61% | 13,90% | 116.057 |
| 13/05/2009 | 10,52 | 10,52 | 9,54 | 9,62 | -9,51% | 9,25% | 171.815 |
| 12/05/2009 | 11,34 | 11,34 | 10,52 | 10,63 | -6,27% | 7,26% | 70.105 |
| 11/05/2009 | 11,12 | 11,57 | 10,97 | 11,34 | -0,66% | 5,39% | 84.318 |
| 08/05/2009 | 11,49 | 11,64 | 10,89 | 11,42 | +1,33% | 6,51% | 73.872 |
| 07/05/2009 | 11,64 | 11,64 | 10,89 | 11,27 | -2,59% | 6,43% | 108.603 |
| 06/05/2009 | 11,64 | 11,68 | 10,97 | 11,57 | +0,65% | 6,11% | 116.324 |
| 05/05/2009 | 11,57 | 11,75 | 11,15 | 11,49 | -1,29% | 5,18% | 96.634 |
| 04/05/2009 | 11,23 | 11,90 | 10,89 | 11,64 | +4,71% | 9,00% | 117.179 |
| 01/05/2009 | 11,19 | 11,53 | 11,08 | 11,12 | -0,67% | 4,01% | 86.001 |
| 30/04/2009 | 11,23 | 11,60 | 11,08 | 11,19 | -0,33% | 4,67% | 179.670 |
| 29/04/2009 | 10,85 | 11,27 | 10,70 | 11,23 | +3,45% | 5,17% | 148.865 |